3 / 5 Stars
5 3 4 1 2
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
U.S. News evaluated 121 Long/Short Equity Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
The fund has returned 36.75 percent over the past year, 6.74 percent over the past three years, and 12.86 percent over the past five years.
|Trailing Returns||Updated 06.30.2014|
|Year to date||13.6%|
|3 Years (Annualized)||6.7%|
|5 Years (Annualized)||12.9%|
|10 Years (Annualized)||N/A|
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of the value of its total assets (net assets plus any borrowings for investment purposes) in securities of companies principally engaged in the design, development, production, sale, management or distribution of products, services or facilities used for or in connection with healthcare or medicine ("healthcare companies"). It may invest up to 20% of the value of its total assets in a wide variety of securities and financial instruments, of all kinds and descriptions, issued by non-healthcare companies. The fund is non-diversified.
Fees are High compared to funds in the same category.
Highland Long/Short Healthcare Fund has an expense ratio of 2.49 percent.
Risk is High compared to funds in the same category according to Morningstar.